Eskelinen M - Search Results

1

GastroPanel® Biomarker Assay: The Most Comprehensive Test for Helicobacter pylori Infection and Its Clinical Sequelae. A Critical Review.

Syrjänen K, Eskelinen M, Peetsalu A, Sillakivi T, Sipponen P, Härkönen M, Paloheimo L, Mäki M, Tiusanen T, Suovaniemi O, DiMARIO F, Fan ZP. Syrjänen K, et al. Among authors: eskelinen m. Anticancer Res. 2019 Mar;39(3):1091-1104. doi: 10.21873/anticanres.13218. Anticancer Res. 2019. PMID: 30842138 Review.

2

Psychosocial risk scale (PRS) for breast cancer in patients with breast disease: a prospective case-control study in Kuopio, Finland.

Eskelinen M, Ollonen P. Eskelinen M, et al. Anticancer Res. 2009 Nov;29(11):4765-70. Anticancer Res. 2009. PMID: 20032433 Free article.

3

Contribution of emotional distance and reserve in patient-physician communication in healthy study patients, and in patients with benign breast disease and breast cancer: a prospective case-control study in Finland.

Eskelinen M, Ollonen P. Eskelinen M, et al. Anticancer Res. 2014 Mar;34(3):1269-74. Anticancer Res. 2014. PMID: 24596371

4

Cholecystectomy Patients with High Plasma Level of Catalase Have Significantly Lower Analgesia Requirement: A Prospective Study of Two Different Cholecystectomy Techniques with Special Reference to Patients with Cancer.

Saimanen I, Kuosmanen V, Kärkkäinen J, Selander T, Aspinen S, Holopainen A, Rantanen T, Eskelinen M. Saimanen I, et al. Among authors: eskelinen m. Anticancer Res. 2018 Sep;38(9):5417-5422. doi: 10.21873/anticanres.12872. Anticancer Res. 2018. PMID: 30194197 Clinical Trial.

5

Nitrotyrosine (NT), a Nitrosative Stress Biomarker, Plasma Concentrations in Gallstone Disease and Cancer Patients.

Saimanen I, Rahkola D, Kuosmanen V, Kärkkäinen J, Selander T, Holopainen A, Aspinen S, Eskelinen M. Saimanen I, et al. Among authors: eskelinen m. Anticancer Res. 2019 Feb;39(2):809-814. doi: 10.21873/anticanres.13179. Anticancer Res. 2019. PMID: 30711961 Clinical Trial.

6

RAND-36-Item Health Survey: A Comprehensive Test for Long-term Outcome and Health Status Following Surgery.

Saimanen I, Kuosmanen V, Rahkola D, Selander T, Kärkkäinen J, Harju J, Aspinen S, Eskelinen M. Saimanen I, et al. Among authors: eskelinen m. Anticancer Res. 2019 Jun;39(6):2927-2933. doi: 10.21873/anticanres.13422. Anticancer Res. 2019. PMID: 31177131

7

Colorectal Cancer Screening With Traditional and New-generation Fecal Immunochemical Tests: A Critical Review of Fecal Occult Blood Tests.

Meklin J, Syrjänen K, Eskelinen M. Meklin J, et al. Among authors: eskelinen m. Anticancer Res. 2020 Feb;40(2):575-581. doi: 10.21873/anticanres.13987. Anticancer Res. 2020. PMID: 32014898 Review.

8

Fecal Occult Blood Tests in Colorectal Cancer Screening: Systematic Review and Meta-analysis of Traditional and New-generation Fecal Immunochemical Tests.

Meklin J, SyrjÄnen K, Eskelinen M. Meklin J, et al. Among authors: eskelinen m. Anticancer Res. 2020 Jul;40(7):3591-3604. doi: 10.21873/anticanres.14349. Anticancer Res. 2020. PMID: 32620599

9

Leucocyte Count Does Not Improve the Diagnostic Performance of a Diagnostic Score (DS) in Distinguishing Acute Appendicitis (AA) from Nonspecific Abdominal Pain (NSAP).

Meklin J, Eskelinen M, Syrjanen K, Eskelinen M. Meklin J, et al. Among authors: eskelinen m. In Vivo. 2020 Nov-Dec;34(6):3327-3339. doi: 10.21873/invivo.12171. In Vivo. 2020. PMID: 33144440 Free PMC article.

10

Gender-specific Performance of a Diagnostic Score in Acute Appendicitis.

Meklin J, Eskelinen M, SyrjÄnen K, Eskelinen M. Meklin J, et al. Among authors: eskelinen m. In Vivo. 2020 Nov-Dec;34(6):3687-3703. doi: 10.21873/invivo.12217. In Vivo. 2020. PMID: 33144486 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

348 results

Search Page